Monthly Archives: September 2019

September 2019

Castle Creek Acquires Fibrocell for Gene Therapies to Treat Rare Skin Disorders

From partner to knight in shining armor: Castle Creek to buy Fibrocell

Exton gene and cell therapy company to be sold in $63.3M deal

Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell

- Castle Creek will advance multiple late-stage clinical development programs targeting epidermolysis bullosa - PARSIPPANY, N.J., September 12, 2019 -- Castle [...]

© 2016 Castle Creek Pharma  -  Terms & Conditions  -  Privacy Policy

Powered by